Mira Pharmaceuticals Inc Ordinary Shares MIRA 深 沪
已收盘 08-01 16:00:00 美东时间
1.54
-0.110
-6.67%
华盛通- 最 高1.65
- 今 开1.65
- 成交量 34.88万股
- 最 低 1.53
- 昨 收 1.65
- 总市值 2605.62万
- 52周最高 2.70
- 市盈率 静 --
- 换手率 2.06%
- 52周最低 0.73
- 委 比 -32.22%
- 总股本 1691.96万
- 历史最高 7.9799
- 量 比 0.59
- 振 幅 7.27%
- 历史最低 0.51
- 每 手 1
- 风险率 0.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MIRA Pharmaceuticals Reports Promising Preclinical Results
MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has provided an announcement. On July 29...
07-30 04:43
MIRA Pharmaceuticals Announces New Preclinical Results From SKNY-1, An Oral Drug Candidate For Obesity And Nicotine Addiction Currently Under Definitive Agreement For Acquisition; Reports Clear Reversal Of Anxiety-Related Behavior In Animal Model
MIRA Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using SKNY-1, an Oral Drug Candidate for Obesity and Nicotine Addiction Under Definitive Agreement for Acquisition SKNY-1 was previously shown
07-11 04:23
MIRA Pharmaceuticals Raises $2M Through Stock Sale
MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has issued an announcement. On July 3, 2...
07-09 05:49
EXCLUSIVE: MIRA Pharmaceuticals' Soon To Be Acquired Weight Loss Drug Reverses Obesity Markers And Cuts Nicotine Craving In Animal Study
MIRA's to be acquired SKNY-1 cut weight and food cravings in animals, reversed liver fat, and reduced nicotine desire—without triggering muscle loss or overstimulation.
06-30 19:20
MIRA Pharmaceuticals Reveals Promising SKNY-1 Preclinical Data
MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has provided an announcement. MIRA Pharm...
06-25 04:40
Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $17.75 Valuation
https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_06182025_MIRA_Sorensen.pdf
06-18 23:07
MIRA Pharma Says First Manuscript Describing Ketamir-2, Currently Being Evaluated In Ongoing Phase 1 Clinical Trial For Neuropathic Pain, Accepted For Publication In Peer-Reviewed Journal Frontiers In Pharmacology
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced that
06-18 20:36
MIRA Pharmaceuticals’ Ketamir-2 Published in Pharmacology Journal
MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has provided an announcement. On June 17...
06-18 04:42
Visionstate Unveils MIRA to Revolutionize Facility Inspections
An announcement from Visionstate ( ($TSE:VIS) ) is now available. Visionstate C...
06-05 23:08
